Endo Health offers $54.5 mln to settle some vaginal mesh cases

Reuters

A unit of Endo Pharmaceuticals Inc said it has agreed to pay $54.5 million to settle some of the thousands of lawsuits in North America that it is facing over injury claims stemming from the use of transvaginal surgical mesh products.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
UnitedHealthcare CEO’s killing unleashes rage against insurers
2
How the new Trump administration could hurt provider finances
3
What to expect in the primary care market in 2030
4
Digital health companies face time crunch with employer contracts
5
'Transparent' CVS, Express Scripts, OptumRx PBMs draw interest